Is a complete LON/0T6G research report available?

No complete published report is available for lon/0T6G (LON/0T6G) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0T6G stock profile: metrics, valuation and analysis

Market cap	264M
Revenue (ttm)	40.5M
Net income (ttm)	25.5M
EPS (ttm)	$1.71
P/E (trailing)	10.4x
Volume	12
Beta	-0.33

All LON/0T6G indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	22
Employees Change	-17%
Employees Change Percent	-39.53
Enterprise value	$189.3M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US7469641051
Last refreshed	2026-09-08
Market cap	$264M
Price	$12.07
Price currency	USD
Rev Per Employee	1,840,980.77x
Sector	Healthcare
Sector PE	21.51
Sector PE Fwd	13.73
Sic	2836
Symbol	lon/0T6G
Website	https://www.q32bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.65%
EV Earnings	7.43x
EV/EBIT	11.93x
EV/EBITDA	10.9x
EV/Sales	4.76x
FCF yield	-5.56%
P/B ratio	3.31x
P/E ratio	10.37x
P/S ratio	6.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.94%
EBITDA Margin	40.6%
Gross margin	73.3%
Gross Profit	$29.7M
Net Income	$25.5M
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	62.87%
Profit Margin	62.87%
Profit Per Employee	$1.2M
Profitable Years	1
ROA	14.74
ROCE	19.43
ROE	72.14
ROIC	22.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	613.22%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth Years	0x
Revenue Growth3 Y	100.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.59
Assets	$87.3M
Cash	$80.1M
Current Assets	$81.1M
Current Liabilities	$4M
Debt	$4M
Debt EBITDA	$0.23
Debt Equity	$0.05
Debt FCF	$-0.27
Equity	$79.8M
Interest Coverage	23.85
Liabilities	$7.5M
Long Term Assets	$6.2M
Long Term Liabilities	$3.5M
Net Cash	$76.1M
Net Cash By Market Cap	$28.83
Net Cash Growth	179.44%
Net Debt EBITDA	$-4.63
Net Debt Equity	$-0.95
Tangible Book Value	$79.8M
Tangible Book Value Per Share	$3.36
WACC	2.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	20.3
Net Working Capital	$-972,273
Quick ratio	19.78
Working Capital	$78.6M
Working Capital Turnover	$0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	612.26%
200-day SMA	8.02
50-day SMA	15.12
50-day SMA vs 200-day SMA	50over200
All Time High	53.4
All Time High Change	-77.4%
All Time High Date	2024-09-11
All Time Low	1.32
All Time Low Change	814.39%
All Time Low Date	2025-07-10
ATR	1.05
Beta	-0.33
Ch YTD	279
High	13.12
High52	23.5
High52 Date	2026-07-14
High52ch	-48.64%
Low	11.75
Low52	1.62
Low52 Date	2025-09-04
Low52ch	645.06%
Ma50ch	-20.17%
Price vs 200-day SMA	50.44%
RSI	28.98
RSI Monthly	52.69
RSI Weekly	54.96
Sharpe ratio	1.77x
Sortino ratio	4.81
Total Return	-21.91%
Tr YTD	279
Tr1m	-21.88%
Tr1w	-22.05%
Tr3m	3.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,435,554%
Net Borrowing	-9,578,991.4
Shares Insiders	0.71%
Shares Institutions	28.05%
Shares Qo Q	44.32%
Shares Yo Y	21.91%
Short Ratio	2.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-19M
Adjusted OCF	-19,020,357.8
Average Volume	1,196.65x
Bv Per Share	3.36
Ch1m	-21.88
Ch1w	-22.05
Ch1y	612.1
Ch3m	3.22
Ch6m	142.4
Change	-7.03%
Change From Open	-4.21
Close	12.98
Days Gap	-2.93
Depreciation Amortization	263,411.2
Dollar Volume	144.8
Earnings Date	2026-11-06
EBIT	$16.2M
EBITDA	$16.4M
EPS	$1.71
F Score	3
FCF	$-14.7M
FCF EV Yield	-7.75x
Financing CF	48,437,284
Fiscal Year End	December
Founded	2,017
Graham Number	9.77796
Graham Upside	-18.99
Investing CF	5,275,900
Is Primary Listing	0
Last Earnings Date	2025-11-06
Last Report Date	2026-06-30
Ma150	9.64
Ma150ch	25.23%
Ma20	15.21
Ma20ch	-20.63%
Net CF	38,768,821
Next Earnings Date	2026-11-06
Open	12.6
Position In Range	23.36
Ppne	4,124,308.5
Price Date	2026-09-04
Price EBITDA	$16.05
Ptbv Ratio	3.31
Relative Volume	0.01x
Revenue	40,501,577x
SBC By Revenue	10.94x
Share Based Comp	4,430,249
Tr6m	142.37%
Volume	12
Z Score	3.36

LON/0T6G (LON/0T6G)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0T6G

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0T6G indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0T6G

Frequently asked questions